Delivery Order SPE2DB22D2206-SPE2DB25FJP70
Award Date 8/22/25
Potential Completion Date 9/15/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,221.60 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialized oncology medication, with performance at the contractor's Conshohocken, Pennsylvania location. The contract is structured as a firm fixed-price delivery order under a non-competitive set-aside, with an ultimate completion date of October 3, 2025. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 16, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,777.70 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Enhertu 100 mg vials, a specialized pharmaceutical product. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award is a non-set-aside competitive procurement, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $14,221.60 on June 30, 2025, for the supply of Enhertu 100 mg vials with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a pediatric-focused pharmaceutical procurement supporting federal medical supply requirements. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,888.50 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a therapeutic oncology medication, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a $17,777.00 delivery order to AmerisourceBergen Drug Corp for 100 milligram vials of Enhertu, a specialty oncology medication. This firm fixed price contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The award was competitively granted without set-aside provisions and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a cancer therapeutic agent. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,221.60 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialty oncology medication, with performance in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on August 6, 2025, was competitively awarded without set-aside designation and is scheduled for completion by August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...